News: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

2.89USD
19 Dec 2014
Price Change (% chg)

$0.04 (+1.40%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.90
Day's Low
$2.79
Volume
208,182
Avg. Vol
1,004,083
52-wk High
$3.49
52-wk Low
$1.70

Search Stocks
Select another date:

Mon, Sep 29 2014

UPDATE 1-Catalyst Pharma's lead drug succeeds in late-stage study

Sept 29 - Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.

BRIEF-Catalyst Pharmaceuticals announces positive top-line PHASE 3 data from Firdapse clinical trial

* Announces positive top-line PHASE 3 data from Firdapse clinical trial in patients with lambert-eaton myasthenic syndrome

Select another date:
Search Stocks